Quest Diagnostics Inc (DGX)
167.55 x 1 184.37 x 1
Post-market by (Cboe BZX)
172.24 +0.10 (+0.06%) 02/21/25 [NYSE]
167.55 x 1 184.37 x 1
Post-market 172.24 unch (unch) 16:08 ET
for Fri, Feb 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 2,621,000 | 2,488,000 | 2,397,000 | 2,366,000 | 2,288,000 |
Cost of Goods | 1,763,000 | 1,677,000 | 1,593,000 | 1,595,000 | 1,552,000 |
Gross Profit | 858,000 | 811,000 | 804,000 | 771,000 | 736,000 |
Operating Expenses | 497,000 | 481,000 | 449,000 | 471,000 | 469,000 |
Operating Income | 361,000 | 330,000 | 355,000 | 300,000 | 267,000 |
Interest Expense | 65,000 | 49,000 | 44,000 | 43,000 | 40,000 |
Other Income | 8,000 | 21,000 | 3,000 | 17,000 | 18,000 |
Pre-tax Income | 304,000 | 302,000 | 314,000 | 274,000 | 245,000 |
Income Tax | 68,000 | 65,000 | 74,000 | 66,000 | 40,000 |
Net Income Continuous | 236,000 | 237,000 | 240,000 | 208,000 | 205,000 |
Minority Interests | 14,000 | 11,000 | 11,000 | 14,000 | 13,000 |
Net Income | $222,000 | $226,000 | $229,000 | $194,000 | $192,000 |
EPS Basic Total Ops | 1.98 | 2.01 | 2.05 | 1.74 | 1.72 |
EPS Basic Continuous Ops | 2.13 | 2.12 | 2.16 | 1.87 | 1.83 |
EPS Diluted Total Ops | 1.95 | 1.99 | 2.03 | 1.72 | 1.70 |
EPS Diluted Continuous Ops | 2.09 | 2.10 | 2.14 | 1.86 | 1.85 |
EPS Diluted Before Non-Recurring Items | 2.23 | 2.30 | 2.35 | 2.04 | 2.15 |
EBITDA(a) | $N/A | $455,000 | $472,000 | $416,000 | $376,000 |